Detalhe da pesquisa
1.
Broadly neutralizing antibodies for HIV treatment and cure approaches.
Curr Opin HIV AIDS
; 18(4): 157-163, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144579
2.
Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1.
iScience
; 26(9): 107628, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664600
3.
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.
J Interferon Cytokine Res
; 41(11): 407-414, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788130
4.
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
EBioMedicine
; 68: 103410, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098342
5.
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.
EBioMedicine
; 64: 103230, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530000
6.
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
EClinicalMedicine
; 35: 100849, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903855
7.
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals.
AIDS
; 33(8): 1315-1325, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30932955
8.
The role of miR-29a in HIV-1 replication and latency.
J Virus Erad
; 3(4): 185-191, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057080